TVU Networks Showcases Game-Changing Cloud Production Partnerships at NAB 2025
TVU Networks announces two groundbreaking partnerships set to revolutionize their cloud production ecosystem, delivering unprecedented capabilities to content creators and broadcasters alike. CUPERTINO, Calif., April 2, 2025 /PRNewswire/ -- In a...
Xobin Recognized in the 2024 Gartner® Market Guide for Developer Skills Assessment and Interview Platforms
CHENNAI, India, April 2, 2025 /PRNewswire/ -- Xobin, a leading skills assessment software, proudly announces its recognition in 2024 Gartner® Market Guide for Developer Skills Assessment and Interview Platforms. With 4 million+ test takers annually...
UY SCUTI ACQUISITION CORP. ANNOUNCES CLOSING OF $50 MILLION INITIAL PUBLIC OFFERING
NEW YORK, April 2, 2025 /PRNewswire/ -- UY Scuti Acquisition Corp. (NASDAQ: UYSCU), (the "Company"), today announced the closing of its initial public offering of 5,000,000 units at an offering price of $10.00 per unit. Each unit consists of one...
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
MELBOURNE, Australia, April 2, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89Zr-olaratumab) in...
Seeing Machines Announces 3D Camera Technology for Next-Generation In-Cabin Monitoring Systems
Seeing Machines and Airy3D partner to supply the Automotive industry with low-impact, trustworthy 3D-vision for future in-cabin systems. CANBERRA, Australia, April 1, 2025 /PRNewswire/ -- Seeing Machines, the advanced computer vision technology...
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic, and immune diseases, announced today that it...
Mega Matrix Inc. Filed 2024 Annual Report on Form 20-F
SINGAPORE, April 1, 2025 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), a short-video streaming platform and producer of short dramas, announces that it has filed its annual report on Form 20-F for the fiscal year...
Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug...
Zeekr Group Announces March 2025 Delivery Update
HANGZHOU, China, April 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for March 2025. In...
Blokees Officially Announces the Launch of the second season of 3rd BFC Creation Competition: Breaking the Cocoon Season
SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1st, the second season of the third BFC (Blokees Figures Creator) Creation Competition, themed "Breaking the Cocoon Season," was officially launched. This year's competition continues to adopt a...